ad_1]
ATLANTA, Oct. 06, 2022 (GLOBE NEWSWIRE) — DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Firm”), a number one supplier of modern well being analysis companies and options to federal companies, right now introduced it has been awarded an Indefinite Supply/Indefinite Amount (ID/IQ) a number of award contract to enhance the Division of Veteran Affairs’ (“VA”) efforts to design, develop, and check improvements in healthcare.
As a part of the Accelerating VA Innovation and Studying (“AVAIL”) contract, DLH will compete with 17 prime awardees for particular person process orders throughout 5 process classes: customized healthcare, knowledge transformation, digital care, immersive know-how (prolonged actuality options), and care and repair supply. The multiple-award contract consists of a five-year base interval and has a $650 million ceiling, in mixture, for all awardees. Particular values might be allotted to contractors as process orders are competed and awarded.
“Making certain Veterans have entry to the very best high quality care is central to the DLH mission, and this contract allows our firm to attach the VA with the rising instruments, superior processes, digital options, and knowledge transformation required to assist their long-standing custom as a pioneer in medical innovation,” stated Jackie Everett, DLH Chief Progress Officer. “DLH will leverage our experience in utilized analysis, genomics, artificial knowledge modeling, augmented and digital actuality, digital well being instruments, and artificial knowledge modeling to assist the design, growth and testing of the following era of medical gadgets wanted by the VA because it accelerates its tempo of modernization.”
“We’re honored for this chance to increase upon our long-standing relationship with the Division of Veterans Affairs, one in all this nation’s preeminent engines of medical innovation,” added Zach Parker, DLH President and CEO. “Beneath this contract, DLH could apply our digital transformation capabilities – spanning synthetic intelligence and machine studying, massive knowledge analytics, telehealth, modeling and simulation, and extra – in direction of enhancing the superior options accessible to Veterans, clinicians, and caregivers.”
About DLH
DLH (NASDAQ:DLHC) delivers improved well being and readiness options for federal packages by analysis, methods growth, and modern care processes. The Firm’s consultants in public well being, efficiency analysis, and well being operations clear up the advanced issues confronted by civilian and army prospects alike, leveraging digital transformation, synthetic intelligence, superior analytics, cloud-based functions, telehealth methods, and extra. With over 2,400 staff devoted to the concept that “Your Mission is Our Ardour,” DLH brings a novel mixture of presidency sector expertise, confirmed methodology, and unwavering dedication to public well being to enhance the lives of tens of millions. For extra data, go to www.DLHcorp.com.
Secure Harbor Assertion beneath the Non-public Securities Litigation Reform Act of 1995:
This press launch could include forward-looking statements throughout the that means of the Non-public Securities Litigation Reform Act of 1995. These statements relate to future occasions or DLH`s future monetary efficiency. Any statements that confer with expectations, projections or different characterizations of future occasions or circumstances or that aren’t statements of historic reality (together with with out limitation statements to the impact that the Firm or its administration “believes”, “expects”, “anticipates”, “plans”, “intends” and related expressions) ought to be thought-about ahead wanting statements that contain dangers and uncertainties which may trigger precise occasions or DLH’s precise outcomes to vary materially from these indicated by the forward-looking statements. Ahead-looking statements on this launch embody, amongst others, statements relating to estimates of future revenues, working revenue, earnings and money movement. These statements replicate our perception and assumptions as to future occasions that won’t show to be correct. Our precise outcomes could differ materially from such forward-looking statements made on this launch attributable to a wide range of elements, together with: the outbreak of the novel coronavirus (“COVID-19”), together with the measures to cut back its unfold, and its affect on the financial system and demand for our companies, are unsure, can’t be predicted, and will precipitate or exacerbate different dangers and uncertainties; the danger that we’ll not notice the anticipated advantages of acquisitions; the challenges of managing bigger and extra widespread operations; contract awards in reference to re-competes for current enterprise and/or competitors for brand new enterprise; compliance with new financial institution monetary and different covenants; modifications in consumer budgetary priorities; authorities contract procurement (corresponding to bid and award protests, small enterprise set asides, lack of work attributable to organizational conflicts of curiosity, and so forth.) and termination dangers; the flexibility to efficiently combine the operations of acquisitions; the affect of inflation and better rates of interest; and different dangers described in our SEC filings. For a dialogue of such dangers and uncertainties which may trigger precise outcomes to vary from these contained within the forward-looking statements, see “Danger Elements” within the Firm’s periodic experiences filed with the SEC, together with our Annual Report on Type 10-Okay for the fiscal 12 months ended September 30, 2021, in addition to subsequent experiences filed thereafter. The forward-looking statements contained herein aren’t historic information, however fairly are based mostly on present expectations, estimates, assumptions and projections about our trade and enterprise.
Such forward-looking statements are made as of the date hereof and will turn out to be outdated over time. The Firm doesn’t assume any duty for updating forward-looking statements, besides as could also be required by regulation.
INVESTOR RELATIONS
Contact: Chris Witty
Cellphone: 646-438-9385
Electronic mail: cwitty@darrowir.com
